For research use only. Not for therapeutic Use.
Ticlopidine HCl is an P2 receptor inhibitor against ADP-induced platelet aggregation with IC50 of ~2 μM.<br>Ticlopidine HCl is an antiplatelet drug in the thienopyridine family. Ticlopidine HCl inhibits platelet aggregation by altering the function of platelet membranes by blocking ADP receptors. This prevents the conformational change of glycoprotein IIb/IIIa which allows platelet binding to fibrinogen.<br>Ticlopidine HCl inhibits platelet aggregation with IC50 of ~2 μM in men.
| Catalog Number | A000939 |
| CAS Number | 53885-35-1 |
| Synonyms | NA |
| Molecular Formula | C₁₄H₁₄ClNS.HCl |
| Purity | ≥95% |
| Target | Adenosine Receptor |
| Solubility | Soluble in DMSO > 10 mM |
| Storage | 3 years -20C powder |
| InChI | 1S/C14H14ClNS.ClH/c15-13-4-2-1-3-11(13)9-16-7-5-14-12(10-16)6-8-17-14;/h1-4,6,8H,5,7,9-10H2;1H |
| InChIKey | MTKNGOHFNXIVOS-UHFFFAOYSA-N |
| SMILES | C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl.Cl |
